Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213 24. 998. Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascu- larized patients with left ventricular dysfunction. J Am Coll Cardiol. 2003;42:2099 105. 999. O Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year expe- rience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90:101 7. 1000. Phillips HR, O Connor CM, Rogers J. Revascularization for heart failure. Am Heart J. 2007;153:65 73. 1001. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation. 2006;113:230 7. 1002. Tsuyuki RT, Shrive FM, Galbraith PD, et al. Revascularization in patients with heart failure. CMAJ. 2006;175:361 5. 1003. Borger van der Burg AE, Bax JJ, Boersma E, et al. Impact of percu- taneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. Am J Cardiol. 2003;91:785 9. 1004. Kaiser GA, Ghahramani A, Bolooki H, et al. Role of coronary artery surgery in patients surviving unexpected cardiac arrest. Surgery. 1975; 78:749 54. 1005. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascular- ization Investigation (BARI). Circulation. 1997;96:1761 9. 1006. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: com- parison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 1007. Hoffman SN, TenBrook JA, Wolf MP, et al. 